UnitedHealth Group Inc. : Good timing to anticipate a continuation of the trend
Entry price | Target | Stop-loss | Potential |
---|
$258.42 |
$287 |
$239 |
+11.06% |
---|
The underlying tendency is to the upside for shares in UnitedHealth Group and the timing is opportune to get back into the stock. A comeback of the upward dynamic can be anticipated.
Summary● The company has strong fundamentals. More than 70% of listed companies have a lower mix of growth, profitability, debt and visibility criteria.
● The company has solid fundamentals for a short-term investment strategy.
Strengths● The share is getting closer to its long-term support in weekly data, at USD 255.98, which offers good timing for buyers.
● Graphically speaking, the timing seems perfect for purchasing the stock close to the USD 256.97 support.
● Predictions on business development from analysts polled by Standard & Poor's are tight. This results from either a good visibility into core activities or accurate earnings releases.
● The group usually releases upbeat results with huge surprise rates.
● The company has attractive valuation levels with a low EV/sales ratio compared with its peers.
● Analysts covering this company mostly recommend stock overweighting or purchase.
● The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
● The tendency within the weekly time frame is positive above the technical support level at 255.98 USD
The content herein constitutes a general investment recommendation, prepared in accordance with provisions aimed at preventing market abuse by Surperformance, the publisher of MarketScreener.com. More specifically, this recommendation is based on factual elements and expresses a sincere, complete, and balanced opinion. It relies on internal or external data, considered reliable as of the date of their release. Nevertheless, this information, and the resulting recommendation, may contain inaccuracies, errors, or omissions, for which Surperformance cannot be held responsible. This recommendation, which in no way constitutes investment advice, may not be suitable for all investor profiles. The reader acknowledges and accepts that any investment in a financial instrument involves risks, for which they assume full responsibility, without recourse against Surperformance. Surperformance commits to disclosing any conflict of interest that may affect the objectivity of its recommendations.
Surperformance is Buy on UNITEDHEALTH GROUP INC. since 2015-11-02
.